John Virostko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Virostko has a total of 260 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Edward Yankeelov
Department of Biomedical Engineering, The University of Texas at Austin, Austin, USA
12 shared publications - Alvin C. Powers
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN
7 shared publications - Daniel Jensen Moore
Department of Pediatrics, Ian Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center 1 , Nashville, TN
7 shared publications - Anum S. Kazerouni
Department of Radiology, University of Washington, Seattle, WA 98195, USA
6 shared publications - Julie C. DiCarlo
Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin
5 shared publications Liping Du
10Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
5 shared publications
Latest Publications
- Open Access
- 26 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (4) , e70254
Prevalence and Incidence of Abdominal Obesity and Cardiometabolic Risk in Early Adolescence
Abdominal obesity and related cardiometabolic risk (CMR) factors frequently begin in adolescence and contribute to long‑term health burden, yet longitudinal trajectories in U.S. youth are poorly characterized. This study quantifies the prevalence and 2‑ and 4‑year incidence of emerging CMR, with emphasis on excess adiposity, in a diverse adolescent cohort. We analyzed longitudinal data from the Adolescent Brain Cognitive Development Study, collected at three time points: 2018–2020 (mean age, 12.1 years), 2020–2022 (mean age, 14.2 years), and 2022–2024 (mean age, 16.1 years). Adolescents ( n = 4788 to 3313) with anthropometric and laboratory data were included. Abdominal obesity was defined as a waist‐to‐height ratio > 0.5. Additional CMR factors included elevated total cholesterol (≥ 145 mg/dL), glycated hemoglobin (HbA1c ≥ 5.7%), and high blood pressure (≥ 95th percentile for age, sex, and height). Weighted prevalence and 2‐ and 4‐year incidence were calculated. At baseline, abdominal obesity affected 38.4% (95% CI: 36.4%–40.4%), followed by elevated cholesterol (17.6%), HbA1c (8.7%), and blood pressure (3.0%). Over a four‐year period, new‐onset abdominal obesity occurred in 10.5% of individuals, compared with 15.4% for cholesterol, 4.7% for HbA1c, and 3.1% for blood pressure. The steepest CMR progression was observed for lipid and adiposity markers. Abdominal obesity is highly prevalent by early adolescence, and new cardiometabolic risk develops rapidly, particularly for adiposity and dyslipidemia. These results highlight the need for early obesity screening and interventions to mitigate long‑term cardiometabolic risk in youth.
- 26 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (4) , e70254
Open AccessPrevalence and Incidence of Abdominal Obesity and Cardiometabolic Risk in Early Adolescence
Abdominal obesity and related cardiometabolic risk (CMR) factors frequently begin in adolescence and contribute to long‑term health burden, yet longitudinal trajectories in U.S. youth are poorly characterized. This study quantifies the prevalence and 2‑ and 4‑year incidence of emerging CMR, with emphasis on excess adiposity, in a diverse adolescent cohort. We analyzed longitudinal data from the Adolescent Brain Cognitive Development Study, collected at three time points: 2018–2020 (mean age, 12.1 years), 2020–2022 (mean age, 14.2 years), and 2022–2024 (mean age, 16.1 years). Adolescents ( n = 4788 to 3313) with anthropometric and laboratory data were included. Abdominal obesity was defined as a waist‐to‐height ratio > 0.5. Additional CMR factors included elevated total cholesterol (≥ 145 mg/dL), glycated hemoglobin (HbA1c ≥ 5.7%), and high blood pressure (≥ 95th percentile for age, sex, and height). Weighted prevalence and 2‐ and 4‐year incidence were calculated. At baseline, abdominal obesity affected 38.4% (95% CI: 36.4%–40.4%), followed by elevated cholesterol (17.6%), HbA1c (8.7%), and blood pressure (3.0%). Over a four‐year period, new‐onset abdominal obesity occurred in 10.5% of individuals, compared with 15.4% for cholesterol, 4.7% for HbA1c, and 3.1% for blood pressure. The steepest CMR progression was observed for lipid and adiposity markers. Abdominal obesity is highly prevalent by early adolescence, and new cardiometabolic risk develops rapidly, particularly for adiposity and dyslipidemia. These results highlight the need for early obesity screening and interventions to mitigate long‑term cardiometabolic risk in youth.
- Open Access
- 23 March 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (13) , 1786-1794
Pancreas Size and Fat Content Increase during Pregnancy and Correlate with Glycemic Control
The pancreas plays a critical role in adapting to the increased metabolic demands and insulin resistance of pregnancy. In rodents, beta cell proliferation during pregnancy induces pancreas growth, but whether similar changes occur in the human pancreas remains unknown. This study characterizes longitudinal changes in the size and composition of the pancreas during pregnancy and postpartum, and examines correlations with breastfeeding, adiposity, and metabolic assays. Sixty-one pregnant women were followed up to three visits during pregnancy (15, 25, and 35 weeks) and three postpartum (6 weeks, 6 months, and 12 months). MRI was conducted to assess pancreas, spleen, and kidney size as well as pancreas, liver, and whole-body adiposity. Glucose tolerance testing was performed at 24 to 28 weeks' gestation. In a subset of participants (n = 58), additional glucose assays were performed at 15 weeks' gestation. Pancreas size was normalized for concurrently measured body weight to calculate pancreas volume index (PVI). The size of the pancreas increased by approximately 20% from 15 to 35 weeks' gestation (p < 0.001) and declined postpartum. PVI was positively correlated with whole-body fat mass (R 2 = 0.12) and fasting blood glucose (R 2 = 0.18) at 15 weeks' gestation. Higher pancreas fat content at 15 weeks predicted impaired response to glucose challenge 10 weeks later (R 2 = 0.33). PVI was low, and pancreatic fat was high at 15 weeks in two participants who were subsequently diagnosed with gestational diabetes mellitus. Any breastfeeding 1-year postpartum correlated with a smaller decline in PVI from 35 weeks' gestation to 1-year postpartum (p < 0.05). Pancreas size and fat content change dynamically during pregnancy and postpartum, and correlate with glucose levels, prenatal adiposity, and breastfeeding. Data are available upon reasonable request from the authors. Received: 10 September 2025 Accepted after revision: 09 March 2026 Article published online: 23 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 23 March 2026
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (13) , 1786-1794
Open AccessPancreas Size and Fat Content Increase during Pregnancy and Correlate with Glycemic Control
The pancreas plays a critical role in adapting to the increased metabolic demands and insulin resistance of pregnancy. In rodents, beta cell proliferation during pregnancy induces pancreas growth, but whether similar changes occur in the human pancreas remains unknown. This study characterizes longitudinal changes in the size and composition of the pancreas during pregnancy and postpartum, and examines correlations with breastfeeding, adiposity, and metabolic assays. Sixty-one pregnant women were followed up to three visits during pregnancy (15, 25, and 35 weeks) and three postpartum (6 weeks, 6 months, and 12 months). MRI was conducted to assess pancreas, spleen, and kidney size as well as pancreas, liver, and whole-body adiposity. Glucose tolerance testing was performed at 24 to 28 weeks' gestation. In a subset of participants (n = 58), additional glucose assays were performed at 15 weeks' gestation. Pancreas size was normalized for concurrently measured body weight to calculate pancreas volume index (PVI). The size of the pancreas increased by approximately 20% from 15 to 35 weeks' gestation (p < 0.001) and declined postpartum. PVI was positively correlated with whole-body fat mass (R 2 = 0.12) and fasting blood glucose (R 2 = 0.18) at 15 weeks' gestation. Higher pancreas fat content at 15 weeks predicted impaired response to glucose challenge 10 weeks later (R 2 = 0.33). PVI was low, and pancreatic fat was high at 15 weeks in two participants who were subsequently diagnosed with gestational diabetes mellitus. Any breastfeeding 1-year postpartum correlated with a smaller decline in PVI from 35 weeks' gestation to 1-year postpartum (p < 0.05). Pancreas size and fat content change dynamically during pregnancy and postpartum, and correlate with glucose levels, prenatal adiposity, and breastfeeding. Data are available upon reasonable request from the authors. Received: 10 September 2025 Accepted after revision: 09 March 2026 Article published online: 23 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- Open Access
- 20 January 2026
- Published by Wiley in Clinical Anatomy
Lifespan Pancreas Morphology for Control Versus Type 2 Diabetes Using AI on Largescale Clinical Imaging
Understanding how pancreas size and shape change with normal aging is critical for establishing a baseline to detect deviations in type 2 diabetes and other pancreatic disease. We measure pancreas size and shape using morphological measurements from early development through aging (ages 0–90). Our goals are to (1) identify reliable clinical imaging modalities for artificial intelligence (AI) based pancreas measurement, (2) establish normative morphological aging trends, and (3) detect potential deviations in type 2 diabetes. We analyzed a clinically acquired dataset of 2533 patients imaged with abdominal computed tomography (CT) or magnetic resonance imaging (MRI). The patients did not have cancer, pancreas pathology, sepsis, or trauma. We resampled the scans to 3 mm isotropic resolution, segmented the pancreas using automated methods, and extracted 13 morphological pancreas features across the lifespan. First, we assessed pancreas volume trajectories in 1858 control patients across contrast CT, non‐contrast CT, and MRI to determine which modalities provide consistent lifespan trends. Second, we characterized distributions of normative morphological patterns stratified by age group and sex. Third, we used covariate‐adjusted generative additive models for location, scale, and shape (GAMLSS) regression to model pancreas morphology trends in 1350 patients matched for age, sex, and type 2 diabetes status to identify any deviations from normative aging associated with type 2 diabetes. We selected CT for the main analyses of this study, since the MRI appeared to yield different pancreas measurements than CT using our AI‐based method on this dataset of clinically acquired scans. When adjusting for confounders, the aging trends for 10 of 13 morphological features were significantly different between patients with type 2 diabetes and non‐diabetic controls ( p < 0.05 after multiple comparisons corrections). Additionally, we characterized normative morphological aging trends of the pancreas across 13 morphological measurements. We provide lifespan trends demonstrating that the size and shape of the pancreas are altered in type 2 diabetes using 675 control patients and 675 diabetes patients. Moreover, our findings reinforce that the pancreas is smaller in type 2 diabetes. Additionally, we contribute a reference of lifespan pancreas morphology from a large cohort of non‐diabetic control patients in a clinical setting.
- 20 January 2026
- Published by Wiley in Clinical Anatomy
Open AccessLifespan Pancreas Morphology for Control Versus Type 2 Diabetes Using AI on Largescale Clinical Imaging
Understanding how pancreas size and shape change with normal aging is critical for establishing a baseline to detect deviations in type 2 diabetes and other pancreatic disease. We measure pancreas size and shape using morphological measurements from early development through aging (ages 0–90). Our goals are to (1) identify reliable clinical imaging modalities for artificial intelligence (AI) based pancreas measurement, (2) establish normative morphological aging trends, and (3) detect potential deviations in type 2 diabetes. We analyzed a clinically acquired dataset of 2533 patients imaged with abdominal computed tomography (CT) or magnetic resonance imaging (MRI). The patients did not have cancer, pancreas pathology, sepsis, or trauma. We resampled the scans to 3 mm isotropic resolution, segmented the pancreas using automated methods, and extracted 13 morphological pancreas features across the lifespan. First, we assessed pancreas volume trajectories in 1858 control patients across contrast CT, non‐contrast CT, and MRI to determine which modalities provide consistent lifespan trends. Second, we characterized distributions of normative morphological patterns stratified by age group and sex. Third, we used covariate‐adjusted generative additive models for location, scale, and shape (GAMLSS) regression to model pancreas morphology trends in 1350 patients matched for age, sex, and type 2 diabetes status to identify any deviations from normative aging associated with type 2 diabetes. We selected CT for the main analyses of this study, since the MRI appeared to yield different pancreas measurements than CT using our AI‐based method on this dataset of clinically acquired scans. When adjusting for confounders, the aging trends for 10 of 13 morphological features were significantly different between patients with type 2 diabetes and non‐diabetic controls ( p < 0.05 after multiple comparisons corrections). Additionally, we characterized normative morphological aging trends of the pancreas across 13 morphological measurements. We provide lifespan trends demonstrating that the size and shape of the pancreas are altered in type 2 diabetes using 675 control patients and 675 diabetes patients. Moreover, our findings reinforce that the pancreas is smaller in type 2 diabetes. Additionally, we contribute a reference of lifespan pancreas morphology from a large cohort of non‐diabetic control patients in a clinical setting.
- Open Access
- 1 November 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (06) , 1-18
Data-driven abdominal phenotypes of type 2 diabetes in lean, overweight, and obese cohorts from computed tomography
PurposeAlthough elevated body mass index (BMI) is a well-known risk factor for type 2 diabetes, the disease’s presence in some lean adults and absence in others with obesity suggests that more detailed measurements of body composition may uncover abdominal phenotypes of type 2 diabetes. With artificial intelligence (AI) and computed tomography (CT), we can now leverage robust image segmentation to extract detailed measurements of size, shape, and tissue composition from abdominal organs, abdominal muscle, and abdominal fat depots in 3D clinical imaging at scale. This creates an opportunity to empirically define body composition signatures linked to type 2 diabetes risk and protection using large-scale clinical data.ApproachWe studied imaging records of 1728 de-identified patients from Vanderbilt University Medical Center with BMI collected from the electronic health record. To uncover BMI-specific diabetic abdominal patterns from clinical CT, we applied our design four times: once on the full cohort (n=1728) and once on lean (n=497), overweight (n=611), and obese (n=620) subgroups separately. Briefly, our experimental design transforms abdominal scans into collections of explainable measurements, identifies which measurements most strongly predict type 2 diabetes and how they contribute to risk or protection, groups scans by shared model decision patterns, and links those decision patterns back to interpretable abdominal phenotypes in the original explainable measurement space of the abdomen using the following steps. (1) To capture abdominal composition: we represented each scan as a collection of 88 automatically extracted measurements of the size, shape, and fat content of abdominal structures using TotalSegmentator. (2) To learn key predictors: we trained a 10-fold cross-validated random forest classifier with SHapley Additive exPlanations (SHAP) analysis to rank features and estimate their risk-versus-protective effects for type 2 diabetes. (3) To validate individual effects: for the 20 highest-ranked features, we ran univariate logistic regressions to quantify their independent associations with type 2 diabetes. (4) To identify decision-making patterns: we embedded the top-20 SHAP profiles with uniform manifold approximation and projection and applied silhouette-guided K-means to cluster the random forest’s decision space. (5) To link decisions to abdominal phenotypes: we fit one-versus-rest classifiers on the original anatomical measurements from each decision cluster and applied a second SHAP analysis to explore whether the random forest’s logic had identified abdominal phenotypes.ResultsAcross the full, lean, overweight, and obese cohorts, the random forest classifier achieved a mean area under the receiver operating characteristic curve (AUC) of 0.72 to 0.74. SHAP highlighted shared type 2 diabetes signatures in each group—fatty skeletal muscle, older age, greater visceral and subcutaneous fat, and a smaller or fat-laden pancreas. Univariate logistic regression confirmed the direction of 14 to 18 of the top 20 predictors within each subgroup (p<0.05). Clustering the model’s decision space further revealed type 2 diabetes-enriched abdominal phenotypes within the lean, overweight, and obese subgroups.ConclusionsWe found similar abdominal signatures of type 2 diabetes across the separate lean, overweight, and obese groups, which suggests that the abdominal drivers of type 2 diabetes may be consistent across weight classes. Although our model had a modest AUC, the explainable components allowed for a clear interpretation of feature importance. In addition, in both lean and obese subgroups, the most important feature for identifying type 2 diabetes was fatty skeletal muscle.
- 1 November 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (06) , 1-18
Open AccessData-driven abdominal phenotypes of type 2 diabetes in lean, overweight, and obese cohorts from computed tomography
PurposeAlthough elevated body mass index (BMI) is a well-known risk factor for type 2 diabetes, the disease’s presence in some lean adults and absence in others with obesity suggests that more detailed measurements of body composition may uncover abdominal phenotypes of type 2 diabetes. With artificial intelligence (AI) and computed tomography (CT), we can now leverage robust image segmentation to extract detailed measurements of size, shape, and tissue composition from abdominal organs, abdominal muscle, and abdominal fat depots in 3D clinical imaging at scale. This creates an opportunity to empirically define body composition signatures linked to type 2 diabetes risk and protection using large-scale clinical data.ApproachWe studied imaging records of 1728 de-identified patients from Vanderbilt University Medical Center with BMI collected from the electronic health record. To uncover BMI-specific diabetic abdominal patterns from clinical CT, we applied our design four times: once on the full cohort (n=1728) and once on lean (n=497), overweight (n=611), and obese (n=620) subgroups separately. Briefly, our experimental design transforms abdominal scans into collections of explainable measurements, identifies which measurements most strongly predict type 2 diabetes and how they contribute to risk or protection, groups scans by shared model decision patterns, and links those decision patterns back to interpretable abdominal phenotypes in the original explainable measurement space of the abdomen using the following steps. (1) To capture abdominal composition: we represented each scan as a collection of 88 automatically extracted measurements of the size, shape, and fat content of abdominal structures using TotalSegmentator. (2) To learn key predictors: we trained a 10-fold cross-validated random forest classifier with SHapley Additive exPlanations (SHAP) analysis to rank features and estimate their risk-versus-protective effects for type 2 diabetes. (3) To validate individual effects: for the 20 highest-ranked features, we ran univariate logistic regressions to quantify their independent associations with type 2 diabetes. (4) To identify decision-making patterns: we embedded the top-20 SHAP profiles with uniform manifold approximation and projection and applied silhouette-guided K-means to cluster the random forest’s decision space. (5) To link decisions to abdominal phenotypes: we fit one-versus-rest classifiers on the original anatomical measurements from each decision cluster and applied a second SHAP analysis to explore whether the random forest’s logic had identified abdominal phenotypes.ResultsAcross the full, lean, overweight, and obese cohorts, the random forest classifier achieved a mean area under the receiver operating characteristic curve (AUC) of 0.72 to 0.74. SHAP highlighted shared type 2 diabetes signatures in each group—fatty skeletal muscle, older age, greater visceral and subcutaneous fat, and a smaller or fat-laden pancreas. Univariate logistic regression confirmed the direction of 14 to 18 of the top 20 predictors within each subgroup (p<0.05). Clustering the model’s decision space further revealed type 2 diabetes-enriched abdominal phenotypes within the lean, overweight, and obese subgroups.ConclusionsWe found similar abdominal signatures of type 2 diabetes across the separate lean, overweight, and obese groups, which suggests that the abdominal drivers of type 2 diabetes may be consistent across weight classes. Although our model had a modest AUC, the explainable components allowed for a clear interpretation of feature importance. In addition, in both lean and obese subgroups, the most important feature for identifying type 2 diabetes was fatty skeletal muscle.
- Open Access
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1676627
A mathematical model of insulin action on acinar tissue linking histology and radiological imaging of the pancreas
The pancreas is smaller in individuals with type 1 and type 2 diabetes. The etiology of this reduced pancreatic volume is not fully understood, but it may be due to loss of insulin’s trophic influence on exocrine pancreatic tissue. Supporting this, histological studies have identified a zone of acinar cell hypertrophy and hyperplasia surrounding pancreatic islets, putatively due to insulin action on peri-islet acinar tissue. This study develops a mathematical model of pancreas size incorporating beta cell density, beta cell clustering, and the magnitude and spatial extent of acinar cell expansion to estimate the relationship between beta cell mass and pancreas size. This model indicates that growth of acinar tissue surrounding the beta cell is sufficient to account for the smaller pancreas volume observed in individuals with diabetes. Furthermore, single beta cells and smaller beta cell clusters have a greater influence on pancreas size on a per cell basis, as larger islets have greater overlap in the zone of insulin action. Thus, changes in pancreas volume may be more sensitive to loss of single beta cells or small islets than larger islets. The model provides a conceptual framework linking histological and radiological imaging to better understand the relationship between pancreas volume and beta cell mass.
- 16 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1676627
Open AccessA mathematical model of insulin action on acinar tissue linking histology and radiological imaging of the pancreas
The pancreas is smaller in individuals with type 1 and type 2 diabetes. The etiology of this reduced pancreatic volume is not fully understood, but it may be due to loss of insulin’s trophic influence on exocrine pancreatic tissue. Supporting this, histological studies have identified a zone of acinar cell hypertrophy and hyperplasia surrounding pancreatic islets, putatively due to insulin action on peri-islet acinar tissue. This study develops a mathematical model of pancreas size incorporating beta cell density, beta cell clustering, and the magnitude and spatial extent of acinar cell expansion to estimate the relationship between beta cell mass and pancreas size. This model indicates that growth of acinar tissue surrounding the beta cell is sufficient to account for the smaller pancreas volume observed in individuals with diabetes. Furthermore, single beta cells and smaller beta cell clusters have a greater influence on pancreas size on a per cell basis, as larger islets have greater overlap in the zone of insulin action. Thus, changes in pancreas volume may be more sensitive to loss of single beta cells or small islets than larger islets. The model provides a conceptual framework linking histological and radiological imaging to better understand the relationship between pancreas volume and beta cell mass.
- Open Access
- 19 July 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (12) , e3945-e3951
Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors
Objective: Pancreas size and fat content differ in individuals with diabetes, but it is not clear how pancreas imaging features are impacted by race, genetics, and lifestyle factors. Methods: We performed cross-sectional analysis of 37 163 UK Biobank participants with pancreas imaging data to investigate racial and genetic influences on pancreas volume index (PVI) and pancreatic fat fraction (PFF). We further assessed the influence of prior glycemic status and lifestyle factors on pancreas size and composition after adjusting for sex and age. Results: White nondiabetic individuals had lower PVI compared to Asian participants (P < .0001), but higher than Black participants (P < .01), whereas PFF was highest in White participants. Similar trends were observed in participants with diagnosed diabetes. When stratified by glycemic status acquired 4 to 14 years before imaging, White and Asian participants exhibited significantly lower PVI and higher PFF with increased hemoglobin A1c. Higher polygenic risk scores for type 2 diabetes and hemoglobin A1c were associated with reduced PVI (ρ = −0.07, P < .0001; and ρ = −0.14, P < .0001, respectively) and elevated PFF (ρ = 0.07, P < .0001 and ρ = 0.18, P < .0001, respectively). In contrast, type 1 diabetes polygenic risk showed no significant association with any pancreas measures. Sedentary lifestyle behaviors associated with type 2 diabetes risk at study baseline correlated with smaller PVI and increased pancreas fat 4 to 14 years later. Conclusion: These findings highlight contributions of race, genetics, and behaviors to pancreatic morphology and fat deposition in glycemic dysregulation.
- 19 July 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (12) , e3945-e3951
Open AccessDeterminants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors
Objective: Pancreas size and fat content differ in individuals with diabetes, but it is not clear how pancreas imaging features are impacted by race, genetics, and lifestyle factors. Methods: We performed cross-sectional analysis of 37 163 UK Biobank participants with pancreas imaging data to investigate racial and genetic influences on pancreas volume index (PVI) and pancreatic fat fraction (PFF). We further assessed the influence of prior glycemic status and lifestyle factors on pancreas size and composition after adjusting for sex and age. Results: White nondiabetic individuals had lower PVI compared to Asian participants (P < .0001), but higher than Black participants (P < .01), whereas PFF was highest in White participants. Similar trends were observed in participants with diagnosed diabetes. When stratified by glycemic status acquired 4 to 14 years before imaging, White and Asian participants exhibited significantly lower PVI and higher PFF with increased hemoglobin A1c. Higher polygenic risk scores for type 2 diabetes and hemoglobin A1c were associated with reduced PVI (ρ = −0.07, P < .0001; and ρ = −0.14, P < .0001, respectively) and elevated PFF (ρ = 0.07, P < .0001 and ρ = 0.18, P < .0001, respectively). In contrast, type 1 diabetes polygenic risk showed no significant association with any pancreas measures. Sedentary lifestyle behaviors associated with type 2 diabetes risk at study baseline correlated with smaller PVI and increased pancreas fat 4 to 14 years later. Conclusion: These findings highlight contributions of race, genetics, and behaviors to pancreatic morphology and fat deposition in glycemic dysregulation.
- Open Access
- 31 May 2025
- Published by SMART-MD Publishing LLC in SMART-MD Journal of Precision Medicine
- Vol. 2 (2) , e105-e109
Imaging Findings of Pancreatic Changes in Type 1 Diabetes
Type 1 diabetes (T1D) is caused by autoimmune destruction of the pancreatic beta cell. However, the pancreas, the site of T1D pathogenesis, is not routinely assessed in T1D. Rather, the disease is diagnosed and monitored by assaying the consequence of the destruction of beta cells: lack of insulin production and dysregulation of blood glucose levels. This assessment of disease symptoms, rather than the cause, has important implications for understanding the natural history and treatment of T1D. Dysregulated glucose is thought to occur only after beta cell mass is greatly reduced, putatively due to compensation for loss of beta cells via increased insulin secretion 1. The autoimmune process underlying T1D can occur years or decades prior to onset of dysglycemia 2, but current clinical practice is limited by a lack of early prediction and interventions intended to prevent beta cell loss. Cross-sectional imaging of the endocrine and exocrine pancreas may provide early predictors of T1D risk and progression. In this review, we summarize current imaging techniques capable of monitoring changes in the pancreas and their potential clinical utility in T1D.
- 31 May 2025
- Published by SMART-MD Publishing LLC in SMART-MD Journal of Precision Medicine
- Vol. 2 (2) , e105-e109
Open AccessImaging Findings of Pancreatic Changes in Type 1 Diabetes
Type 1 diabetes (T1D) is caused by autoimmune destruction of the pancreatic beta cell. However, the pancreas, the site of T1D pathogenesis, is not routinely assessed in T1D. Rather, the disease is diagnosed and monitored by assaying the consequence of the destruction of beta cells: lack of insulin production and dysregulation of blood glucose levels. This assessment of disease symptoms, rather than the cause, has important implications for understanding the natural history and treatment of T1D. Dysregulated glucose is thought to occur only after beta cell mass is greatly reduced, putatively due to compensation for loss of beta cells via increased insulin secretion 1. The autoimmune process underlying T1D can occur years or decades prior to onset of dysglycemia 2, but current clinical practice is limited by a lack of early prediction and interventions intended to prevent beta cell loss. Cross-sectional imaging of the endocrine and exocrine pancreas may provide early predictors of T1D risk and progression. In this review, we summarize current imaging techniques capable of monitoring changes in the pancreas and their potential clinical utility in T1D.
- Open Access
- 1 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (02) , 1-12
Influence of early through late fusion on pancreas segmentation from imperfectly registered multimodal magnetic resonance imaging
PurposeCombining different types of medical imaging data, through multimodal fusion, promises better segmentation of anatomical structures, such as the pancreas. Strategic implementation of multimodal fusion could improve our ability to study diseases such as diabetes. However, where to perform fusion in deep learning models is still an open question. It is unclear if there is a single best location to fuse information when analyzing pairs of imperfectly aligned images or if the optimal fusion location depends on the specific model being used. Two main challenges when using multiple imaging modalities to study the pancreas are (1) the pancreas and surrounding abdominal anatomy have a deformable structure, making it difficult to consistently align the images and (2) breathing by the individual during image collection further complicates the alignment between multimodal images. Even after using state-of-the-art deformable image registration techniques, specifically designed to align abdominal images, multimodal images of the abdomen are often not perfectly aligned. We examine how the choice of different fusion points, ranging from early in the image processing pipeline to later stages, impacts the segmentation of the pancreas on imperfectly registered multimodal magnetic resonance (MR) images.ApproachOur dataset consists of 353 pairs of T2-weighted (T2w) and T1-weighted (T1w) abdominal MR images from 163 subjects with accompanying pancreas segmentation labels drawn mainly based on the T2w images. Because the T2w images were acquired in an interleaved manner across two breath holds and the T1w images on one breath hold, there were three different breath holds impacting the alignment of each pair of images. We used deeds, a state-of-the-art deformable abdominal image registration method to align the image pairs. Then, we trained a collection of basic UNets with different fusion points, spanning from early to late layers in the model, to assess how early through late fusion influenced segmentation performance on imperfectly aligned images. To investigate whether performance differences on key fusion points are generalized to other architectures, we expanded our experiments to nnUNet.ResultsThe single-modality T2w baseline using a basic UNet model had a median Dice score of 0.766, whereas the same baseline on the nnUNet model achieved 0.824. For each fusion approach, we analyzed the differences in performance with Dice residuals, by subtracting the baseline score from the fusion score for each datapoint. For the basic UNet, the best fusion approach was from early/mid fusion and occurred in the middle of the encoder with a median Dice residual of +0.012 compared with the baseline. For the nnUNet, the best fusion approach was early fusion through naïve image concatenation before the model, with a median Dice residual of +0.004 compared with the baseline. After Bonferroni correction, the distributions of the Dice scores for these best fusion approaches were found to be statistically significant (p<0.05) via the paired Wilcoxon signed-rank test against the baseline.ConclusionsFusion in specific blocks can improve performance, but the best blocks for fusion are model-specific, and the gains are small. In imperfectly registered datasets, fusion is a nuanced problem, with the art of design remaining vital for uncovering potential insights. Future innovation is needed to better address fusion in cases of imperfect alignment of abdominal image pairs. The code associated with this project is available here https://github.com/MASILab/influence_of_fusion_on_pancreas_segmentation.
- 1 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (02) , 1-12
Open AccessInfluence of early through late fusion on pancreas segmentation from imperfectly registered multimodal magnetic resonance imaging
PurposeCombining different types of medical imaging data, through multimodal fusion, promises better segmentation of anatomical structures, such as the pancreas. Strategic implementation of multimodal fusion could improve our ability to study diseases such as diabetes. However, where to perform fusion in deep learning models is still an open question. It is unclear if there is a single best location to fuse information when analyzing pairs of imperfectly aligned images or if the optimal fusion location depends on the specific model being used. Two main challenges when using multiple imaging modalities to study the pancreas are (1) the pancreas and surrounding abdominal anatomy have a deformable structure, making it difficult to consistently align the images and (2) breathing by the individual during image collection further complicates the alignment between multimodal images. Even after using state-of-the-art deformable image registration techniques, specifically designed to align abdominal images, multimodal images of the abdomen are often not perfectly aligned. We examine how the choice of different fusion points, ranging from early in the image processing pipeline to later stages, impacts the segmentation of the pancreas on imperfectly registered multimodal magnetic resonance (MR) images.ApproachOur dataset consists of 353 pairs of T2-weighted (T2w) and T1-weighted (T1w) abdominal MR images from 163 subjects with accompanying pancreas segmentation labels drawn mainly based on the T2w images. Because the T2w images were acquired in an interleaved manner across two breath holds and the T1w images on one breath hold, there were three different breath holds impacting the alignment of each pair of images. We used deeds, a state-of-the-art deformable abdominal image registration method to align the image pairs. Then, we trained a collection of basic UNets with different fusion points, spanning from early to late layers in the model, to assess how early through late fusion influenced segmentation performance on imperfectly aligned images. To investigate whether performance differences on key fusion points are generalized to other architectures, we expanded our experiments to nnUNet.ResultsThe single-modality T2w baseline using a basic UNet model had a median Dice score of 0.766, whereas the same baseline on the nnUNet model achieved 0.824. For each fusion approach, we analyzed the differences in performance with Dice residuals, by subtracting the baseline score from the fusion score for each datapoint. For the basic UNet, the best fusion approach was from early/mid fusion and occurred in the middle of the encoder with a median Dice residual of +0.012 compared with the baseline. For the nnUNet, the best fusion approach was early fusion through naïve image concatenation before the model, with a median Dice residual of +0.004 compared with the baseline. After Bonferroni correction, the distributions of the Dice scores for these best fusion approaches were found to be statistically significant (p<0.05) via the paired Wilcoxon signed-rank test against the baseline.ConclusionsFusion in specific blocks can improve performance, but the best blocks for fusion are model-specific, and the gains are small. In imperfectly registered datasets, fusion is a nuanced problem, with the art of design remaining vital for uncovering potential insights. Future innovation is needed to better address fusion in cases of imperfect alignment of abdominal image pairs. The code associated with this project is available here https://github.com/MASILab/influence_of_fusion_on_pancreas_segmentation.
- 23 August 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (11) , e1366-e1371
Can generative AI improve the readability of patient education materials at a radiology practice?
- 23 August 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (11) , e1366-e1371
Can generative AI improve the readability of patient education materials at a radiology practice?
- 19 April 2024
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (10) , e313-e320
Changes in Pancreas Volume in Living Donor Liver Transplant Recipients
Background.: Metabolic factors have a significant role in the morbidity and mortality associated with chronic liver disease. The pancreas has a central role in metabolism and metabolic risk factors but has been largely ignored in liver transplantation. Small pancreas volume has been demonstrated in pathologic conditions such as type 1 and 2 diabetes. Methods.: This study assessed abdominal imaging before and after liver transplantation to determine if liver transplantation induces changes in pancreas volume in living donor liver transplant recipients. Our secondary outcome is to correlate pancreas volume with demographic, clinical, and outcome data. We conducted a retrospective study of pancreas volume in patients enrolled in the adult-to-adult living donor liver transplantation cohort study. Pancreas volume was manually calculated from 413 MRI or computed tomography images and correlated with imaging and clinical data. Results.: Pancreas volume declined by an average of 24% (87.8 ± 25.2 mL to 66.8 ± 20.4 mL, P < 0.0001), regardless of liver disease etiology. Pancreas volume correlated with portal blood flow, spleen volume, and liver enzyme levels. We found a correlation between smaller pancreas volume pretransplant and longer intensive care unit (ICU) stay across all patients (P < 0.05). Individuals with an ICU stay of P < 0.05). Conclusions.: Pancreas volume is dynamic in liver transplant recipients and may reflect altered metabolism and risk of posttransplantation complications.
- 19 April 2024
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (10) , e313-e320
Changes in Pancreas Volume in Living Donor Liver Transplant Recipients
Background.: Metabolic factors have a significant role in the morbidity and mortality associated with chronic liver disease. The pancreas has a central role in metabolism and metabolic risk factors but has been largely ignored in liver transplantation. Small pancreas volume has been demonstrated in pathologic conditions such as type 1 and 2 diabetes. Methods.: This study assessed abdominal imaging before and after liver transplantation to determine if liver transplantation induces changes in pancreas volume in living donor liver transplant recipients. Our secondary outcome is to correlate pancreas volume with demographic, clinical, and outcome data. We conducted a retrospective study of pancreas volume in patients enrolled in the adult-to-adult living donor liver transplantation cohort study. Pancreas volume was manually calculated from 413 MRI or computed tomography images and correlated with imaging and clinical data. Results.: Pancreas volume declined by an average of 24% (87.8 ± 25.2 mL to 66.8 ± 20.4 mL, P < 0.0001), regardless of liver disease etiology. Pancreas volume correlated with portal blood flow, spleen volume, and liver enzyme levels. We found a correlation between smaller pancreas volume pretransplant and longer intensive care unit (ICU) stay across all patients (P < 0.05). Individuals with an ICU stay of P < 0.05). Conclusions.: Pancreas volume is dynamic in liver transplant recipients and may reflect altered metabolism and risk of posttransplantation complications.